Artesunate/mefloquine Artesunate/mefloquine Artesunate/mefloquine is a medication used to treat malaria. It is a fixed dose combination of artesunate and mefloquine. Specifically it is recommended to treat uncomplicated falciparum malaria. It is taken by mouth. Side effects are similar to the medications being used separately. Use is recommended as it decreases the possibility of either medications being used alone. Dose forms appropriate for children are also available. Artesunate/mefloquine came into commercial use in 2008. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is approved for medical use
International Association for the Treatment of Sexual Offenders medical treatments, or other psychical interventions. Probation supervision and residential placement are not considered treatment for this specific age group. However, they are still important aspects of intervention with juvenile sexual offenders. Family sometimes is a reason as to why juveniles offend. Some characteristics of the family of a juvenile sexual offender are troubled adolescent behavior, environment (can be either advantage or disadvantage neighborhoods, as in both good or both), and also has shown effects such as use of aggression and/or force. When a professional is deciding on a treatment for the adolescent they need to view the adolescent within